Clinical trials
Completed Gaucher Disease trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 3 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shire | 4 |
| Genzyme, a Sanofi Company | 3 |
| Pfizer | 3 |
| Amicus Therapeutics | 2 |
| Idorsia Pharmaceuticals Ltd. | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| Sanofi | 1 |
| Spur Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gaucher Disease | 16 |
| Gangliosidoses, GM2 | 1 |
| Gangliosidosis, GM1 | 1 |
| Lysosomal Storage Diseases | 1 |
| Myoclonus | 1 |
| Sandhoff Disease | 1 |
| Tay-Sachs Disease | 1 |
| Tay-Sachs Disease, AB Variant | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.